The Food and Drug Administration is set to approve new boosters that specifically target the omicron mutation of COVID-19.
Both the Moderna and Pfizer vaccines have been updated to protect against the highly contagious variants as well as the first strain.
The omicron variants have long been the dominant strains, leading to reinfections and an increase in vaccinated people contracting the virus.
